Highnoon Laboratories Limited (PSX:HINOON)
1,029.02
+4.54 (0.44%)
At close: Jan 16, 2026
Highnoon Laboratories Market Cap
Highnoon Laboratories has a market cap or net worth of 54.52 billion as of January 16, 2026. Its market cap has increased by 10.99% in one year.
Market Cap
54.52B
Enterprise Value
52.68B
Revenue
26.61B
Ranking
n/a
PE Ratio
14.84
Stock Price
1,029.02
Market Cap Chart
Since July 1, 1996, Highnoon Laboratories's market cap has increased from 188.06M to 54.52B, an increase of 28,891.97%. That is a compound annual growth rate of 21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 54.52B | 0.64% |
| Dec 31, 2025 | 54.17B | 11.36% |
| Dec 31, 2024 | 48.65B | 81.98% |
| Dec 29, 2023 | 26.73B | 18.17% |
| Dec 30, 2022 | 22.62B | -5.37% |
| Dec 31, 2021 | 23.91B | 15.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 135.90B |
| Abbott Laboratories (Pakistan) | 117.50B |
| The Searle Company | 75.04B |
| AGP Limited | 60.27B |
| Shifa International Hospitals | 34.67B |
| Citi Pharma | 19.38B |
| Ferozsons Laboratories | 18.04B |
| Macter International | 15.39B |